These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12089922)

  • 41. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
    Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K
    Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Biochemical and histological spectrum of renal osteodystrophy in Argentina].
    Douthat WG; Garay G; de Arteaga J; Fernández Martín JL; Cannata Andía JB; Massari PU
    Nefrologia; 2003; 23 Suppl 2():47-51. PubMed ID: 12778854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parathyroid hormone and biochemical profile in chronic kidney disease patients in South India.
    Sankarasubbaiyan S; Abraham G; Soundararajan P; Chandrasekaran V; Padma G
    Hemodial Int; 2005 Jan; 9(1):63-7. PubMed ID: 16191055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Marked improvement in parameters of renal osteodystrophy with the use of intraperitoneal calcitriol.
    Arora N; Sandroni S; Moles K
    Adv Perit Dial; 1992; 8():62-4. PubMed ID: 1361854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal osteodystrophy and secondary hyperparathyroidism.
    Fukagawa M; Kazama JJ; Kurokawa K
    Nephrol Dial Transplant; 2002; 17 Suppl 10():2-5. PubMed ID: 12386262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal osteodystrophy.
    Dabbagh S
    Curr Opin Pediatr; 1998 Apr; 10(2):190-6. PubMed ID: 9608898
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous vitamin D therapy reduces PTH-(1-84)/large C fragments ratio in chronic hemodialysis patients.
    Kihara T; Ichikawa H; Morimoto H; Yano A; Akagi S; Nakao K; Kohmoto H; Wada J; Kumagai I; Makino H
    Nephron Clin Pract; 2004; 98(3):c93-100. PubMed ID: 15528944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E
    J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330
    [No Abstract]   [Full Text] [Related]  

  • 51. Cell biology of renal osteodystrophy.
    Kuizon BD; Salusky IB
    Pediatr Nephrol; 2002 Oct; 17(10):777-89. PubMed ID: 12376803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [K/DOQI clinical practice guidelines for management of renal osteodystrophy in predialysis patients].
    Okada N; Tsubakihara Y
    Clin Calcium; 2004 May; 14(5):698-706. PubMed ID: 15577030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of parathyroid-gland function in haemodialysis patients with different forms of renal osteodystrophy.
    Felsenfeld AJ; Rodriguez M; Dunlay R; Llach F
    Nephrol Dial Transplant; 1991; 6(4):244-51. PubMed ID: 1881578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PTH(1-84)/PTH(7-84): a balance of power.
    Friedman PA; Goodman WG
    Am J Physiol Renal Physiol; 2006 May; 290(5):F975-84. PubMed ID: 16601298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
    Morio K; Koide K
    Nihon Rinsho; 1995 Apr; 53(4):958-64. PubMed ID: 7752492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bone histomorphometry is still the golden standard for diagnosing renal osteodystrophy.
    Pecovnik Balon B; Bren A
    Clin Nephrol; 2000 Dec; 54(6):463-9. PubMed ID: 11140807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: effect of age, gender, and race.
    Soeiro EMD; Castro L; Menezes R; Elias RM; Dos Reis LM; Jorgetti V; Moysés RMA
    Pediatr Nephrol; 2020 Jul; 35(7):1297-1305. PubMed ID: 32157445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The renal bone diseases in children treated with dialysis.
    Sanchez CP; Salusky IB
    Adv Ren Replace Ther; 1996 Jan; 3(1):14-23. PubMed ID: 8620364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of renal bone disease.
    Ferreira A
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():2-12. PubMed ID: 16884393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of early renal osteodystrophy.
    Eke FU; Winterborn MH; Robertson PW
    Child Nephrol Urol; 1988-1989; 9(1-2):33-7. PubMed ID: 3251619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.